Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on June 16, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Clinical Research Products Management

Awarded
NIAID-DAIDS-NIHAI201800016Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Awarded on June 16, 2020, to Fisher BioServices, Inc., this contract establishes the Clinical Research Products Management Center (CRPMC) to support domestic and international clinical research trials sponsored by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The primary focus of the center is HIV/AIDS and its co-morbidities. The contractor is responsible for providing cGMP-compliant facilities to handle the receipt, storage, labeling, packaging, repackaging, shipping, acquisition, and disposition of study products. The total estimated value of the contract is 85,983,493 dollars, with a period of performance extending through June 15, 2027. Beyond core product management, the contract includes options for the contractor to provide additional clinical site pharmacy oversight and support for other high-priority NIAID sponsored clinical trials on a limited, as-needed basis. The project is managed under solicitation number NIAID-DAIDS-NIHAI201800016 and falls under NAICS code 561910.

General Info

Contract Value

$62,984,999.47

NAICS

561910 - Packaging and Labeling Services

Place of Performance

MD, USA

Set-Aside

NONE

Award Issued Date

Documents

1

Award Synopsis - Clinical Research Products Management Center (CRPMC)

PDF, Low priorityaward
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

3 updates
PhaseAwarded
Posted

Sources Sought

Notice updated

Response deadline changed from Aug 8, 2018 to Aug 9, 2018. The notice description changed.

Type Changed

Sources Sought → Presolicitation

Notice updated

The notice description changed.

Type Changed

Presolicitation → Solicitation

Notice updated

Notice details unchanged. Attachments may have changed.

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts2 people available
OfficeBETHESDA, MD, 20892, USA

Full Description

Show more
This contract is for the management and operation of the CRPMC to support NIAID sponsored domestic and international clinical research trials, with a core focus of HIV/AIDS and its co-morbidities. The Contractor shall provide cGMP-compliant facilities for receipt, storage, labeling, packaging, repackaging, shipping, acquiring, and disposition of study products. Through the exercise of Options, the contract may provide additional clinical site pharmacy oversight responsibilities, as well as support for other high-priority, NIAID sponsored clinical trials on a limited, as-needed basis.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

in about 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS